Target Name: KRT83
NCBI ID: G3889
Review Report on KRT83 Target / Biomarker Content of Review Report on KRT83 Target / Biomarker
KRT83
Other Name(s): Hb-3 | Keratin 83 | KRTHB3 | type-II keratin Kb23 | Keratin, type II cuticular Hb3 | Type-II keratin Kb23 | keratin 83, type II | Keratin-83 | type II hair keratin Hb3 | Keratin, hair, basic, 3 | Keratin, type II cuticular HB3 | hard keratin, type II, 3 | Hair keratin K2.10 | Type II hair keratin Hb3 | keratin, hair, basic, 3 | K83 | hHb3 | KRT83_HUMAN | Hard keratin, type II, 3 | keratin 83 | MNLIX | EKVP5 | hair keratin K2.10 | HB3

KRT83 (Hb-3): Potential Drug Targets and Biomarkers

KRT83 (Hb-3) is a protein that is expressed in the human body and is found in various tissues, including the liver, spleen, and blood vessels. It is a member of the Hb family, which is a group of proteins that are responsible for carrying oxygen in the blood. Hb-3 is a subunit of the Hb protein and is expressed at a level of around 16% in human adults.

KRT83 (Hb-3) has been shown to have various functions in the body, including its role in oxygen transport and its involvement in the immune response. Hb-3 is also expressed in the liver and has been shown to play a role in the detoxification of harmful substances in the body.

One of the potential uses for KRT83 (Hb-3) as a drug target or biomarker is its role in the development of certain diseases. For example, studies have shown that high levels of Hb-3 are associated with an increased risk of developing cirrhosis, a type of liver disease. Additionally, Hb-3 has been shown to be involved in the development of certain types of cancer, including liver cancer.

Another potential use for KRT83 (Hb-3) as a drug target or biomarker is its role in the immune response. Hb-3 is a component of the immune system and has been shown to play a role in protecting the body against infection and disease. Additionally, Hb-3 has been shown to be involved in the regulation of the immune response, which may have implications for the development of certain immune-related diseases.

In addition to its potential use as a drug target or biomarker, KRT83 (Hb-3) has also been shown to have potential utility in the development of certain therapies. For example, studies have shown that administering Hb-3 to individuals with certain types of cancer has been shown to improve the effectiveness of certain chemotherapy drugs. Additionally, Hb-3 has been shown to have potential utility in the development of regenerative medicine therapies, as it has been shown to promote the growth and regeneration of certain types of tissue.

Overall, KRT83 (Hb-3) is a protein that has been shown to have various functions in the body, including its role in oxygen transport, the immune response, and cancer development. As a result, KRT83 (Hb-3) may be a promising drug target or biomarker for the development of various diseases. Further research is needed to fully understand the role of KRT83 (Hb-3) in the body and its potential utility as a drug or biomarker.

Protein Name: Keratin 83

The "KRT83 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT83 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KRT84 | KRT85 | KRT86 | KRT87P | KRT89P | KRT8P10 | KRT8P11 | KRT8P12 | KRT8P14 | KRT8P16 | KRT8P17 | KRT8P18 | KRT8P22 | KRT8P23 | KRT8P25 | KRT8P26 | KRT8P29 | KRT8P3 | KRT8P33 | KRT8P36 | KRT8P37 | KRT8P39 | KRT8P41 | KRT8P44 | KRT8P45 | KRT8P46 | KRT8P47 | KRT8P48 | KRT8P49 | KRT8P5 | KRT8P7 | KRT8P8 | KRT8P9 | KRT9 | KRT90P | KRTAP1-1 | KRTAP1-3 | KRTAP1-4 | KRTAP1-5 | KRTAP10-1 | KRTAP10-10 | KRTAP10-11 | KRTAP10-12 | KRTAP10-2 | KRTAP10-3 | KRTAP10-4 | KRTAP10-5 | KRTAP10-6 | KRTAP10-7 | KRTAP10-8 | KRTAP10-9 | KRTAP11-1 | KRTAP12-1 | KRTAP12-2 | KRTAP12-3 | KRTAP12-4 | KRTAP13-1 | KRTAP13-2 | KRTAP13-3 | KRTAP13-4 | KRTAP15-1 | KRTAP16-1 | KRTAP17-1 | KRTAP19-1 | KRTAP19-2 | KRTAP19-3 | KRTAP19-4 | KRTAP19-5 | KRTAP19-6 | KRTAP19-7 | KRTAP19-8 | KRTAP2-1 | KRTAP2-2 | KRTAP2-3 | KRTAP2-4 | KRTAP20-1 | KRTAP20-2 | KRTAP20-3 | KRTAP20-4 | KRTAP21-1 | KRTAP21-2 | KRTAP21-3 | KRTAP22-1 | KRTAP22-2 | KRTAP23-1 | KRTAP25-1 | KRTAP26-1 | KRTAP27-1 | KRTAP29-1 | KRTAP3-1 | KRTAP3-2 | KRTAP3-3 | KRTAP4-1 | KRTAP4-11 | KRTAP4-12 | KRTAP4-2 | KRTAP4-3 | KRTAP4-4 | KRTAP4-5 | KRTAP4-6